Market Value5,416,834,000
Total Holdings80
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RVMD / Revolution Medicines, Inc.
GRTSQ / Gritstone bio, Inc.
TNDM / Tandem Diabetes Care, Inc.
CNC / Centene Corporation
PPD / PPD Inc
CABA / Cabaletta Bio, Inc.
CTLT / Catalent, Inc.
QURE / uniQure N.V.
AMED / Amedisys, Inc.
HOOK / HOOKIPA Pharma Inc.
HRC / Hill-Rom Holdings Inc
US55027E1029 / Luminex Corporation
SLQT / SelectQuote, Inc.
RPRX / Royalty Pharma plc
SNY / Sanofi - Depositary Receipt (Common Stock)
SWAV / Shockwave Medical, Inc.
OVID / Ovid Therapeutics Inc.
ADPT / Adaptive Biotechnologies Corporation
GOSS / Gossamer Bio, Inc.
CLDX / Celldex Therapeutics, Inc.
CSLT / Castlight Health Inc - Class B
ODT / Odonate Therapeutics Inc
SYRS / Syros Pharmaceuticals, Inc.
BURNING ROCK BIOTECH LTD / SPONSORED ADS (12233L107)
CYRX / Cryoport, Inc.
AXNX / Axonics, Inc.
/ Immunomedics, Inc.
US29266S3040 / Endologix, Inc.
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
US74257L1089 / Principia Biopharma Inc.
UNH / UnitedHealth Group Incorporated
NVRO / Nevro Corp.
KRYS / Krystal Biotech, Inc.
WVE / Wave Life Sciences Ltd.
TWST / Twist Bioscience Corporation
NVS / Novartis AG - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
GH / Guardant Health, Inc.
PROF / Profound Medical Corp.
VAPO / Vapotherm, Inc.
CLVS / Clovis Oncology Inc
ZNTL / Zentalis Pharmaceuticals, Inc.
US69354M1080 / PRA Health Sciences Inc
IGMS / IGM Biosciences, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
AKRO / Akero Therapeutics, Inc.
MRK / Merck & Co., Inc.
US3723091043 / GenMark Diagnostics, Inc
ARGX / argenx SE - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
PAYX / Paychex, Inc.
ARDX / Ardelyx, Inc.
GMXAY / Genmab A/S
ICUI / ICU Medical, Inc.
XERS / Xeris Biopharma Holdings, Inc.
EPZM / Epizyme Inc
APRE / Aprea Therapeutics, Inc.
SGEN / Seagen Inc
ONEM / 1life Healthcare Inc
AYLA / Ayala Pharmaceuticals Inc
ZYME / Zymeworks Inc.
STOK / Stoke Therapeutics, Inc.
REPL / Replimune Group, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
CI / The Cigna Group
BEAM / Beam Therapeutics Inc.
GLYC / GlycoMimetics, Inc.
CBAY / CymaBay Therapeutics, Inc.
TCRR / Tcr2 Therapeutics Inc
BCEL / Atreca, Inc.
NLTX / Neoleukin Therapeutics, Inc.
BSX / Boston Scientific Corporation
FOLD / Amicus Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
DXCM / DexCom, Inc.
STXS / Stereotaxis, Inc.
IMGN / ImmunoGen, Inc.
ALLK / Allakos Inc.
RPTX / Repare Therapeutics Inc.
NVTA / Invitae Corporation
ADCT / ADC Therapeutics SA
RGNX / REGENXBIO Inc.
SRRK / Scholar Rock Holding Corporation
FATE / Fate Therapeutics, Inc.
ATRA / Atara Biotherapeutics, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
PLRX / Pliant Therapeutics, Inc.
IMVT / Immunovant, Inc.